ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	38/679	73/6049	5.58564632551331e-18	2.63642506564228e-15	2.22249927478319e-15	6356/6357/6362/6347/6364/6368/6369/6348/6351/9560/6355/1437/1440/6376/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3589/3605/3552/3553/3557/11009/90865/3569/4312/4314/5008/5196/6696/8741	38
WP5055	Burn wound healing	44/679	97/6049	1.16521672866149e-17	2.74991147964111e-15	2.31816801807391e-15	8038/6347/57124/1139/1277/1278/2919/3579/1634/2200/2335/10468/3082/3383/3552/3553/3569/3624/3791/3853/3956/23643/407024/4312/4322/4313/79148/4314/100463486/64332/64127/5159/6282/6280/8796/871/6423/6678/7042/7043/7076/7097/51311/3371	44
WP2806	Complement system	36/679	75/6049	1.23856009876469e-15	1.94866788872311e-13	1.64272181520369e-13	133/715/716/717/719/720/722/728/27202/729/1604/22918/629/3075/3426/5199/10332/1380/1634/2214/2219/2357/2769/3383/3673/3687/3690/3915/5648/5329/5806/6401/6403/710/6696/7097	36
WP558	Complement and coagulation cascades	27/679	48/6049	3.13113635924225e-14	3.69474090390585e-12	3.1146566941936e-12	712/713/715/716/717/719/721/728/729/1604/629/3075/3426/1380/2149/2153/2155/3827/5648/5327/5328/5329/5104/5054/710/7056/7450	27
WP5115	Network map of SARS-CoV-2 signaling pathway	56/679	190/6049	2.62897505183328e-12	2.48175244893062e-10	2.09211067282733e-10	350/8542/684/715/716/6356/6347/6364/6348/6351/6355/9332/1051/629/3075/3426/5199/1294/1514/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/2247/2335/3091/10964/2537/8519/10410/3458/3605/8807/3552/3553/90865/3569/3699/116844/64386/114548/5196/5743/6288/6289/6403/5104/5054/6772/7018	56
WP455	GPCRs, class A rhodopsin-like	39/679	118/6049	1.45851592927985e-10	1.14736586436682e-08	9.67226353101377e-09	134/147/187/719/27202/1230/729230/1232/1237/10803/3577/3579/1909/2149/2151/9002/2867/2357/2358/2359/54328/2842/2850/2861/2828/8111/8843/3274/64106/4886/4887/5540/53829/9934/5031/5724/5737/5739/56670	39
WP2911	miRNA targets in ECM and membrane receptors	15/679	22/6049	3.92499610104162e-10	2.64656879955949e-08	2.23105041532892e-08	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/2335/22801/3910/3915/7058	15
WP3624	Lung fibrosis	23/679	52/6049	1.47938367832072e-09	8.72836370209224e-08	7.3579872421741e-08	6356/6347/6348/6351/729230/1232/1051/1437/1440/2920/2247/2252/26585/3082/3553/3569/4313/5155/5328/5806/6696/7015/7076	23
WP545	Complement activation	12/679	18/6049	3.5750928335311e-08	1.87493757491853e-06	1.58056735798217e-06	712/713/715/716/717/720/721/729/1604/629/5199/5648	12
WP5090	Complement system in neuronal development and plasticity	30/679	94/6049	5.00075501323323e-08	2.36035636624608e-06	1.98977410000227e-06	712/713/715/716/717/719/720/721/722/725/728/27202/729/1604/629/3075/3426/5199/10584/1380/6376/2219/8547/3458/3687/3690/5648/710/7042/7043	30
WP24	Peptide GPCRs	18/679	41/6049	1.0681561412619e-07	4.58336089705105e-06	3.86376097030619e-06	719/728/1230/729230/1232/1237/10803/3577/3579/1909/2357/2358/2359/4886/4887/5540/6869/7253	18
WP2431	Spinal cord injury	30/679	98/6049	1.42731354169862e-07	5.61409993068124e-06	4.73267121721122e-06	199/301/63827/713/6347/729230/1280/1282/2919/3627/2920/2212/2697/3383/3458/3552/3553/3554/3569/10288/11025/4321/4843/9423/5743/6098/6403/6869/8741/1462	30
WP2865	IL1 and megakaryocytes in obesity	13/679	23/6049	1.5770476610778e-07	5.72589612329785e-06	4.82691510840006e-06	6347/1232/2149/3383/3458/3553/3554/114548/7941/6280/8991/7076/7097	13
WP5088	Prostaglandin signaling	14/679	28/6049	3.94250055409489e-07	1.32918590109485e-05	1.1205001574796e-05	834/6347/6348/729230/2919/3627/4283/3458/3605/3552/3553/3569/114548/9536	14
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	57/679	265/6049	5.92807211617513e-07	1.86536669255644e-05	1.57249912976435e-05	284/285/1302/1277/1278/1280/1281/1282/1284/1289/1290/50509/1292/9586/1440/1441/1944/2149/2255/2247/2252/2321/2335/59345/2791/51764/3082/3091/3559/3563/22801/3673/3678/8516/3687/3690/3791/284217/3908/3910/3915/10319/4843/4846/5008/9180/5155/5159/5209/5228/6515/6696/7010/7058/3371/7143/7450	57
WP2848	Pluripotent stem cell differentiation pathway	15/679	34/6049	1.16312475166434e-06	3.4312180174098e-05	2.89250760611263e-05	3577/2255/2247/10468/3082/3589/3569/3624/10637/5155/6469/7018/7043/7472/7474	15
WP129	Matrix metalloproteinases	12/679	24/6049	2.74007842908634e-06	7.27526308172843e-05	6.13302730796911e-05	4312/4319/4321/4322/4323/4327/4313/64386/79148/4314/4316/7076	12
WP3967	miR-509-3p alteration of YAP1/ECM axis	10/679	17/6049	2.77446473455745e-06	7.27526308172843e-05	6.13302730796911e-05	1277/1281/1289/1909/2335/10082/6678/7004/7058/7291	10
WP619	Type II interferon signaling	14/679	34/6049	7.16691774651032e-06	0.000178041325071204	0.000150088360564039	3627/4283/2633/3383/2537/3458/3553/4843/5698/8651/9021/6688/6772/6890	14
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	20/679	63/6049	9.51960026552407e-06	0.000224662566266368	0.000189389942124637	6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/84868/8519/3569/5196/6772/7020	20
WP2328	Allograft rejection	22/679	76/6049	1.81109574108696e-05	0.000407065328472879	0.00034315498252174	23743/712/713/717/720/721/729/1604/941/942/1289/6373/4283/50943/3002/3458/3605/3552/3553/3559/120892/6772	22
WP4172	PI3K-Akt signaling pathway	55/679	281/6049	1.90579793795009e-05	0.000408880284869291	0.000344684985906762	284/285/1277/1278/1280/1282/1284/1291/1292/1293/131873/9586/1440/1441/1944/2149/2255/2247/2252/2321/2335/59345/2791/51764/3082/3559/3563/3569/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/4846/4915/5008/9180/5155/5159/5228/8503/10110/6696/7010/7058/7097/3371/7143/7450	55
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/679	24/6049	2.07397235254318e-05	0.000425615195826253	0.000358792471057813	6348/6351/1230/729230/1232/1437/3458/3595/8809/7042/7043	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	9/679	17/6049	2.83704170036468e-05	0.000557951534405053	0.000470351650323618	6347/3383/3553/5196/6401/6403/7042/7043/7097	9
WP4754	IL-18 signaling pathway	48/679	239/6049	3.29081090069661e-05	0.000621305098051521	0.000523758534931924	59/11096/6362/6347/6364/6348/6351/1051/9076/1277/1278/1281/2920/2921/2335/2523/338442/3383/3458/10068/8809/8807/3553/3559/3569/81618/4312/4322/4323/4313/4314/4688/4776/64332/4843/51299/7941/5743/5806/9021/6696/6869/7018/7052/7076/7127/79931/80149	48
WP5087	Malignant pleural mesothelioma	68/679	381/6049	4.77605039179899e-05	0.000867036840357354	0.000730909736072881	59/9510/284/285/834/6347/6351/29126/1009/1012/1014/1001/1003/1004/1282/1284/1437/1440/115908/2919/3627/6374/1944/2255/2247/2252/2321/2335/8061/11211/3082/3091/3620/3553/3569/3673/3690/3791/284217/3908/3910/3915/10319/26524/4323/4313/4314/114548/4915/5155/5159/5163/5228/5328/4920/6401/6422/6423/8140/64321/6678/6772/7004/7010/7015/7472/7474/25937	68
WP530	Cytokines and inflammatory response	9/679	19/6049	8.75287129433797e-05	0.0015301315744176	0.00128989682232349	1437/1440/2919/2920/3458/3589/3552/3553/3569	9
WP1533	Vitamin B12 metabolism	13/679	37/6049	0.000109574738161965	0.00184711701473027	0.00155711470019635	19/6347/2155/3383/3458/3553/3569/5327/6288/6289/5054/6648/6947	13
WP3617	Photodynamic therapy-induced NF-kB survival signaling	12/679	33/6049	0.000137907622952797	0.00224456544943863	0.00189216266701116	597/1437/2920/3383/3552/3553/3569/4312/4313/4314/5743/6401	12
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	18/679	65/6049	0.000193963586808625	0.00299904544755475	0.00252818728629727	947/2354/8456/94234/10468/2619/284110/3458/3488/5653/5650/8549/4488/22822/6275/6422/11005/7474	18
WP2877	Vitamin D receptor pathway	31/679	143/6049	0.000200715719040638	0.00299904544755475	0.00252818728629727	11096/147/768/634/9075/1543/1594/1555/1577/168002/1673/50486/3091/3488/9173/5653/3827/126364/639/5744/6273/6275/6279/6280/6422/219855/6696/79689/7042/7056/54210	31
WP4891	COVID-19 adverse outcome pathway	7/679	13/6049	0.000203325115088457	0.00299904544755475	0.00252818728629727	6347/6348/1440/3627/3553/3559/3569	7
WP2849	Hematopoietic stem cell differentiation	14/679	46/6049	0.000341216451313795	0.00488042924303368	0.0041141887909606	947/1437/1440/2354/2624/3552/3553/3569/3690/4582/4778/861/6688/7068	14
WP474	Endochondral ossification	16/679	57/6049	0.00036810803673298	0.00496419980965619	0.00418480715443809	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/5744/871/6696/6772/7042	16
WP4808	Endochondral ossification with skeletal dysplasias	16/679	57/6049	0.00036810803673298	0.00496419980965619	0.00418480715443809	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/5744/871/6696/6772/7042	16
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	12/679	37/6049	0.000471330035692677	0.00617966046797065	0.00520943723660327	84674/834/50506/3553/4210/4671/58484/91662/114548/64127/639/8767	12
WP15	Selenium micronutrient network	16/679	59/6049	0.000562640257473691	0.00717746490615087	0.00605058370768294	19/247/6347/2155/3383/3458/3553/3569/8942/5327/10549/5743/6288/6289/5054/6648	16
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10/679	28/6049	0.000590042362402851	0.00732894723826699	0.00617828290826254	6347/29126/941/942/3627/3559/8651/7042/7043/51311	10
WP5097	CCL18 signaling pathway	12/679	39/6049	0.00080550409927756	0.00974866499638483	0.00821809850275081	59/1237/1278/1437/2335/3091/4313/6615/6772/7004/7020/7291	12
WP306	Focal adhesion	35/679	183/6049	0.000979655362178299	0.0115599332737039	0.00974499281324729	87/1277/1278/1280/1282/1284/1290/50509/1292/2268/2321/2335/3055/3082/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/5155/5159/5228/8503/399694/6696/7058/3371/7143/7450	35
WP5094	Orexin receptor pathway	24/679	112/6049	0.00121759448425005	0.0140171852820981	0.01181644968027	2920/1846/2354/3091/9456/3383/3553/3569/3777/3908/4023/23764/7873/4322/4314/4846/64106/8013/5069/5163/861/6401/6696/3371	24
WP453	Inflammatory response pathway	9/679	26/6049	0.00143362306610929	0.0161111925524663	0.0135816922052459	941/942/1277/1278/1281/2335/3458/3559/3915	9
WP4823	Genes controlling nephrogenesis	10/679	32/6049	0.00191271178178038	0.0209953479302405	0.0176990221178209	2296/2737/3237/8516/3791/4868/5155/5159/6092/6469	10
WP716	Vitamin A and carotenoid metabolism	10/679	34/6049	0.00315950374295801	0.0338928583335496	0.0285715888717256	127/8854/83875/1381/1382/56603/4023/29881/116362/195814	10
WP1539	Angiogenesis	8/679	24/6049	0.00344682203179344	0.0361533333112556	0.0304771632284894	284/2247/2321/3091/3791/4846/5155/7010	8
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	10/679	35/6049	0.00398833974846065	0.040294086016403	0.0339678066775209	284/285/597/3091/3485/4843/5743/5054/6515/7043	10
WP272	Blood clotting cascade	6/679	15/6049	0.00401233483637912	0.040294086016403	0.0339678066775209	2153/2155/5327/5328/5054/7450	6
WP5092	Interactions of natural killer cells in pancreatic cancer	8/679	25/6049	0.00457979745662091	0.0450346749901056	0.0379641104956733	6347/6348/6351/1437/2214/2624/3002/3458	8
WP4496	Signal transduction through IL1R	9/679	31/6049	0.0055344277648767	0.0526019467778646	0.0443433003613578	3552/3553/3554/3556/3557/3569/11213/7042/7043	9
WP176	Folate metabolism	12/679	48/6049	0.00557224012477379	0.0526019467778646	0.0443433003613578	19/6347/2155/3383/3458/3553/3569/5327/6288/6289/5054/6648	12
WP4493	Cells and molecules involved in local acute inflammatory response 	6/679	16/6049	0.00581926242863115	0.0538567032610569	0.0454010567187322	729/3383/3552/3569/3827/6403	6
WP117	GPCRs, other	10/679	37/6049	0.00615502917270807	0.0558687263368886	0.0470971867871184	27202/3577/3579/1909/2149/11245/53831/59340/53829/5737	10
WP5188	Retinol metabolism	5/679	12/6049	0.00708190345910586	0.0630690270320371	0.0531670210038136	316/1543/1551/10170/195814	5
WP2197	Endothelin pathways	8/679	27/6049	0.00767838820967165	0.0671148006475003	0.0565775973344226	10203/1909/2769/51764/4846/4886/23236/5739	8
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/679	22/6049	0.00817735685951271	0.0701765897761818	0.0591586773759963	2919/2920/2247/3553/5155/6469/30812	7
WP4541	Hippo-Merlin signaling dysregulation	20/679	102/6049	0.00859116035959533	0.0724112087451607	0.0610424551865984	1009/1012/1014/1001/1003/1004/3627/2321/22801/3673/3678/8516/3687/3690/3791/26524/4915/5159/7004/7010	20
WP3937	Microglia pathogen phagocytosis pathway	10/679	39/6049	0.0091419988462637	0.0743969561282149	0.0627164349162918	712/713/2207/2209/3055/4688/8503/54210/54209/7305	10
WP4329	miRNAs involvement in the immune response in sepsis	10/679	39/6049	0.0091419988462637	0.0743969561282149	0.0627164349162918	6348/6351/3002/3383/3552/3569/3934/407008/407024/51311	10
WP3929	Chemokine signaling pathway	27/679	152/6049	0.00994844512777065	0.0795875610221652	0.0670921009508886	6356/6364/6369/6348/6351/1230/729230/1232/1237/10803/6376/3627/6373/2921/6374/4283/3579/2268/59345/2791/51764/3055/5196/8503/23236/399694/6772	27
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	12/679	52/6049	0.0108720702129839	0.0841248711562031	0.070917041251215	1003/1277/1278/2321/3082/3791/4313/8829/91584/6615/7042/7043	12
WP5222	2q13 copy number variation syndrome	12/679	52/6049	0.0108720702129839	0.0841248711562031	0.070917041251215	55289/1437/3552/3553/3554/3556/8808/3557/3569/8651/9021/6772	12
WP5198	Inflammatory bowel disease signaling	9/679	35/6049	0.0128892866904473	0.0981248922240501	0.0827190215448058	50943/3458/3595/8807/3552/3569/64127/6772/7097	9
WP98	Prostaglandin synthesis and regulation	10/679	41/6049	0.0131273847523775	0.0983512000495586	0.0829097984360686	1645/301/308/1909/3290/9536/5737/5739/5743/6916	10
WP4239	Epithelial to mesenchymal transition in colorectal cancer	24/679	135/6049	0.0144289684556307	0.10423949393241	0.0878736144211661	9076/51208/9075/9073/1282/1284/2335/94234/11211/3091/3678/26524/4313/4854/4855/8828/8503/6615/6678/7042/7043/7291/7472/7474	24
WP12	Osteoclast signaling	5/679	14/6049	0.0147967078251514	0.10423949393241	0.0878736144211661	1513/8111/3690/5155/6696	5
WP4210	Tryptophan catabolism leading to NAD+ production	5/679	14/6049	0.0147967078251514	0.10423949393241	0.0878736144211661	3620/8942/10135/23057/6999	5
WP5063	FOXP3 in COVID-19	5/679	14/6049	0.0147967078251514	0.10423949393241	0.0878736144211661	941/942/50943/3559/3569	5
WP5083	Neuroinflammation and glutamatergic signaling	21/679	115/6049	0.0159929204551003	0.111009683158931	0.0935808658208653	816/1610/2247/2898/2906/116443/3458/3552/3553/3554/3569/80131/23236/29968/6507/6515/92745/9021/6772/7042/7043	21
WP2406	Cardiac progenitor differentiation	8/679	31/6049	0.018244813372112	0.12480510016865	0.105210365441012	2247/2626/3624/3791/3084/4920/64321/7070	8
WP1992	Genes targeted by miRNAs in adipocytes	4/679	10/6049	0.0189807862849425	0.127984730378469	0.107890785198621	2078/2697/9464/3759	4
WP727	Monoamine transport	6/679	21/6049	0.0242301400886157	0.161079241152488	0.135789369214184	273/3553/3554/3690/6853/6999	6
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	7/679	27/6049	0.0259561371877207	0.165948649006672	0.13989426700384	6347/2977/3553/3569/4312/4314/23657	7
WP465	Tryptophan metabolism	8/679	33/6049	0.026290301103283	0.165948649006672	0.13989426700384	8854/316/1543/1545/9420/3620/8942/6999	8
WP5218	Extrafollicular B cell activation by SARS-CoV-2	13/679	65/6049	0.0263987622031073	0.165948649006672	0.13989426700384	57379/60468/720/941/1380/8519/3458/3569/3687/639/57823/8741/7494	13
WP3413	NOTCH1 regulation of endothelial cell calcification	5/679	16/6049	0.0267205451790404	0.165948649006672	0.13989426700384	249/813/2702/4256/5327	5
WP4478	LTF danger signal response pathway	5/679	16/6049	0.0267205451790404	0.165948649006672	0.13989426700384	3552/3553/3569/7097/54210	5
WP4707	Aspirin and miRNAs	4/679	11/6049	0.0272291665842912	0.166911254906304	0.140705741201122	283120/4846/5163/5743	4
WP4747	Netrin-UNC5B signaling pathway	10/679	46/6049	0.0286374979443657	0.173293577304367	0.146086021902432	249/6347/1003/1277/3383/3552/3791/9423/54538/6401	10
WP3941	Oxidative damage response	9/679	40/6049	0.0300913802988872	0.179786474697149	0.151559517028372	712/713/715/716/717/719/721/728/1380	9
WP4008	NO/cGMP/PKG mediated neuroprotection	8/679	34/6049	0.0311179409004446	0.183595851312623	0.154770811320633	816/1261/2906/2977/3458/3553/4843/4846	8
WP289	Myometrial relaxation and contraction pathways	22/679	131/6049	0.0337450594181005	0.195945215830552	0.1651812925601	59/133/816/2697/59345/2791/51764/2981/3485/3488/3553/3569/23764/4846/5142/5333/10266/10268/64407/5999/8490/8787	22
WP3287	Overview of nanoparticle effects	5/679	17/6049	0.0344564680379997	0.195945215830552	0.1651812925601	1001/1282/2335/3569/5743	5
WP4830	GDNF/RET signaling axis	5/679	17/6049	0.0344564680379997	0.195945215830552	0.1651812925601	2296/2737/26585/6092/64321	5
WP3527	Pre-implantation embryo	8/679	35/6049	0.0365190236293328	0.200394595555802	0.168932107761136	366/55509/2354/94234/2624/4603/30812/7004	8
WP4136	Fibrin complement receptor 3 signaling pathway	8/679	35/6049	0.0365190236293328	0.200394595555802	0.168932107761136	6347/3627/2921/3569/23643/4843/5327/7305	8
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	13/679	68/6049	0.0369410634970882	0.200394595555802	0.168932107761136	816/6347/1594/1673/10964/3458/3569/64127/23236/5333/6772/7097/51311	13
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4/679	12/6049	0.0373027981468838	0.200394595555802	0.168932107761136	2099/2335/8061/7076	4
WP4538	Regulatory circuits of the STAT3 signaling pathway	14/679	75/6049	0.0373617042561666	0.200394595555802	0.168932107761136	1271/1438/1439/1441/2149/2151/9002/3595/3601/3559/3563/9180/5159/9021	14
WP3670	Interactions between LOXL4 and oxidative stress pathway	5/679	18/6049	0.043442316200762	0.227830813852885	0.192060766361264	308/1280/2252/2335/3490	5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5/679	18/6049	0.043442316200762	0.227830813852885	0.192060766361264	1014/1004/2335/6615/3371	5
WP75	Toll-like receptor signaling pathway	15/679	84/6049	0.0451877903103185	0.234380626664509	0.197582241032972	6348/6351/941/942/3627/6373/4283/3553/3569/23643/8503/6696/6772/7097/51311	15
WP4331	Neovascularisation processes	8/679	37/6049	0.049132107200198	0.247210116304394	0.208397466465345	284/3091/3791/4854/4855/5155/7042/7043	8
WP4723	Omega-3 / omega-6 fatty acid synthesis	4/679	13/6049	0.0492325231623157	0.247210116304394	0.208397466465345	2180/2182/54898/3992	4
WP4724	Omega-9 fatty acid synthesis	4/679	13/6049	0.0492325231623157	0.247210116304394	0.208397466465345	2180/2182/54898/3992	4
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	21/679	129/6049	0.050095473489304	0.248895405125805	0.209818160431656	116/720/721/1051/1103/1139/2328/2624/2697/3091/3359/3552/3553/3557/3569/3764/4915/6507/6869/7018/7068	21
WP4969	RAS and bradykinin pathways in COVID-19	6/679	25/6049	0.0538395251980864	0.264710998890592	0.223150663649963	3552/3553/3827/4846/5054/710	6
WP43	Oxidation by cytochrome P450	8/679	38/6049	0.0563800348753264	0.274344087228393	0.231271331338832	1543/1545/56603/1594/1555/1577/1551/9420	8
WP3971	OSX and miRNAs in tooth development	4/679	14/6049	0.0630068492971815	0.303461559880303	0.255817282860737	249/407024/4854/4855	4
WP5053	Development of ureteric collection system	10/679	53/6049	0.0674784194453745	0.32171529270926	0.271205130785237	2296/80144/341640/10468/2737/3237/8516/6092/6469/7042	10
WP5122	Prostaglandin and leukotriene metabolism in senescence 	6/679	27/6049	0.0743890034742797	0.350038158309464	0.295081230689067	247/3488/23236/9536/5743/6916	6
WP4816	TGF-beta receptor signaling in skeletal dysplasias	10/679	54/6049	0.0749022330280845	0.350038158309464	0.295081230689067	25805/2022/2200/10468/3458/3624/10637/5054/6696/6772	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	4/679	15/6049	0.0785770147435975	0.360081077271631	0.303547384497495	19/9388/4023/255738	4
WP5174	Ulcerative colitis signaling	4/679	15/6049	0.0785770147435975	0.360081077271631	0.303547384497495	50943/3458/64127/7097	4
WP1591	Heart development	7/679	34/6049	0.0794624537192868	0.360637289956763	0.304016270302535	2255/2296/2626/9464/23493/4776/6469	7
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	6/679	28/6049	0.086121774303971	0.387137880680708	0.326356197362416	9509/1277/1278/60681/4015/871	6
WP236	Adipogenesis	18/679	115/6049	0.0895334035272096	0.394200026908499	0.332309567732856	1051/1271/56603/2624/2626/3091/3569/4023/10135/5008/5346/5054/8651/9021/6695/6772/7291/25937	18
WP4540	Hippo signaling regulation pathways	14/679	85/6049	0.0899927096717432	0.394200026908499	0.332309567732856	1009/1012/1014/1001/1003/1004/2321/3791/26524/4915/5159/23236/7004/7010	14
WP2371	Parkinson's disease pathway	7/679	35/6049	0.0901983112417753	0.394200026908499	0.332309567732856	2861/120892/100506755/6622/9627/9246/7345	7
WP1423	Ganglio sphingolipid metabolism	3/679	10/6049	0.0926671304088576	0.401274179385145	0.338273059338949	8708/2523/30815	3
WP247	Small ligand GPCRs	4/679	16/6049	0.0958625045984498	0.4076315510853	0.343632306668696	5724/5737/5739/9294	4
WP516	Hypertrophy model	4/679	16/6049	0.0958625045984498	0.4076315510853	0.343632306668696	3458/3552/3554/8013	4
WP2374	Oncostatin M signaling pathway	11/679	64/6049	0.0979995765066773	0.41299821527814	0.34815639022109	6347/1051/3091/4312/4322/4314/5008/9180/5054/9021/6772	11
WP560	TGF-beta receptor signaling	9/679	50/6049	0.101686798978092	0.424744859448312	0.358058779820388	25805/2022/10468/3458/3624/10637/5054/6696/6772	9
WP2880	Glucocorticoid receptor pathway	11/679	65/6049	0.106678638462485	0.437010021979266	0.368398279010176	6347/6364/3589/89795/5142/5743/5272/1836/5552/7056/84951	11
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/679	23/6049	0.107400768113549	0.437010021979266	0.368398279010176	285/2022/2200/10631/5054	5
WP3893	Development and heterogeneity of the ILC family	5/679	23/6049	0.107400768113549	0.437010021979266	0.368398279010176	3458/3605/3553/90865/3569	5
WP3874	Canonical and non-canonical TGF-B signaling	4/679	17/6049	0.114756669693973	0.455169311727355	0.38370651167025	26585/4015/4016/4017	4
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	4/679	17/6049	0.114756669693973	0.455169311727355	0.38370651167025	249/1594/6098/6696	4
WP691	Tamoxifen metabolism	4/679	17/6049	0.114756669693973	0.455169311727355	0.38370651167025	1543/1545/1577/2328	4
WP3630	NAD metabolism, sirtuins and aging	3/679	11/6049	0.11720636684307	0.457201695453959	0.385419805712749	3091/10135/6098	3
WP5052	Nephrogenesis	3/679	11/6049	0.11720636684307	0.457201695453959	0.385419805712749	8854/4211/84870	3
WP5036	Angiotensin II receptor type 1 pathway	5/679	24/6049	0.123815303793752	0.479023142546318	0.403815227213444	59/1277/1278/3091/3589	5
WP2858	Ectoderm differentiation	18/679	121/6049	0.128776874831534	0.494168170085237	0.416582444897903	91653/6347/1004/54898/2737/57476/9687/3853/9079/4061/22871/5783/4920/6469/6622/6781/7020/7022	18
WP3927	BMP signaling in eyelid development	4/679	18/6049	0.135132199263462	0.51086471794048	0.430657590056872	2255/2296/6422/6469	4
WP2064	Neural crest differentiation	11/679	68/6049	0.135292563013898	0.51086471794048	0.430657590056872	1004/1302/1280/2247/23493/4488/4854/4855/6615/7020/7291	11
WP4565	Neural crest cell migration in cancer	7/679	39/6049	0.140697839759458	0.518266411894115	0.436897198251506	1009/2047/2151/4313/4915/8503/7291	7
WP4900	Purinergic signaling	5/679	25/6049	0.141309248442668	0.518266411894115	0.436897198251506	134/5027/53829/9934/5031	5
WP2882	Nuclear receptors meta-pathway	36/679	268/6049	0.14234024086402	0.518266411894115	0.436897198251506	8647/874/6347/6364/1543/1545/1555/1577/1551/2099/3082/3458/3589/3553/55554/23764/89795/3084/5142/5155/9588/5743/5272/1836/154091/6515/29986/160728/11254/23657/8140/5552/27286/7042/7056/84951	36
WP2881	Estrogen receptor pathway	3/679	12/6049	0.143840889741799	0.518266411894115	0.436897198251506	1543/1545/2099	3
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3/679	12/6049	0.143840889741799	0.518266411894115	0.436897198251506	55509/1437/6688	3
WP4495	IL-10 anti-inflammatory signaling pathway 	3/679	12/6049	0.143840889741799	0.518266411894115	0.436897198251506	3552/3569/6772	3
WP5130	Th17 cell differentiation pathway	10/679	62/6049	0.151804913666987	0.542817570081953	0.457593758900487	50943/3091/3458/3605/3553/3559/3569/861/9021/6772	10
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	5/679	26/6049	0.159805225619616	0.562896018600437	0.474519837267986	9536/5737/5739/5743/6916	5
WP4875	Disruption of postsynaptic signaling by CNV	5/679	26/6049	0.159805225619616	0.562896018600437	0.474519837267986	816/2906/9456/22871/57555	5
WP3646	Hepatitis C and hepatocellular carcinoma	8/679	48/6049	0.16421008595598	0.574127115342391	0.483987621764995	1284/3577/3091/3569/4312/4843/5743/7345	8
WP4298	Acute viral myocarditis	12/679	79/6049	0.170667062786506	0.580638890469885	0.489477030770777	199/834/1232/1604/941/3458/3569/3908/64127/6444/8651/6772	12
WP1434	Osteopontin signaling	3/679	13/6049	0.172223399715644	0.580638890469885	0.489477030770777	3690/5328/6696	3
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	3/679	13/6049	0.172223399715644	0.580638890469885	0.489477030770777	249/6422/7015	3
WP3958	GPR40 pathway	3/679	13/6049	0.172223399715644	0.580638890469885	0.489477030770777	23236/5333/113026	3
WP554	ACE inhibitor pathway	3/679	13/6049	0.172223399715644	0.580638890469885	0.489477030770777	1511/3827/4846	3
WP5121	Sphingolipid metabolism in senescence	5/679	27/6049	0.179218003379919	0.58916518829558	0.496664677019914	23236/9294/55512/8877/7015	5
WP167	Eicosanoid synthesis	4/679	20/6049	0.179745311683397	0.58916518829558	0.496664677019914	247/9536/5743/6916	4
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	4/679	20/6049	0.179745311683397	0.58916518829558	0.496664677019914	2626/3569/3791/6696	4
WP5044	Kynurenine pathway and links to cell senescence	4/679	20/6049	0.179745311683397	0.58916518829558	0.496664677019914	3620/3458/8942/6999	4
WP364	IL6 signaling pathway	7/679	42/6049	0.185794962579018	0.60479463680894	0.509840260289428	3055/3569/639/9021/6772/7076/7432	7
WP2324	AGE/RAGE pathway	10/679	65/6049	0.188183274098029	0.608373324481298	0.512857084420006	249/3091/4322/4323/4313/4316/4481/4843/4846/6772	10
WP4561	Cell migration and invasion through p75NTR	5/679	28/6049	0.199456314048604	0.631460985375842	0.532319920767325	1009/1944/4313/4915/7291	5
WP1602	Nicotine effect on dopaminergic neurons	3/679	14/6049	0.202009731647952	0.631460985375842	0.532319920767325	1138/3777/6571	3
WP3935	Leptin-insulin signaling overlap	3/679	14/6049	0.202009731647952	0.631460985375842	0.532319920767325	8503/8651/9021	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/679	14/6049	0.202009731647952	0.631460985375842	0.532319920767325	941/942/8503	3
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	7/679	43/6049	0.202014001677441	0.631460985375842	0.532319920767325	816/2906/116443/9456/4915/8503/85358	7
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/679	21/6049	0.203669175940858	0.632446388447926	0.533150612919974	941/942/3101/6515	4
WP4564	Neural crest cell migration during development	6/679	36/6049	0.211313990279242	0.651896754325506	0.549547219302054	1009/2047/2151/4313/8503/7291	6
WP4018	Clear cell renal cell carcinoma pathways	12/679	83/6049	0.216694317557021	0.664154012252688	0.559880054932017	1012/2321/3091/3101/3759/3791/5155/5159/29968/10993/7042/7043	12
WP2118	Arrhythmogenic right ventricular cardiomyopathy	9/679	60/6049	0.226376174170761	0.689351962636124	0.581121859670952	87/2697/22801/3673/3678/8516/3690/3908/6444	9
WP3591	Sleep regulation	4/679	22/6049	0.228454929026218	0.691222605771633	0.582698806828004	134/3569/22871/4887	4
WP4842	Mammalian disorder of sexual development	3/679	15/6049	0.23286791087404	0.699903941508497	0.590017149621347	10468/2626/30812	3
WP536	Calcium regulation in cardiac cells	17/679	125/6049	0.234289878725302	0.699903941508497	0.590017149621347	147/777/816/2697/2701/2702/2707/127534/10052/59345/2791/51764/5350/64407/5999/8490/8787	17
WP4197	Immune response to tuberculosis	4/679	23/6049	0.253940015534148	0.735842628326237	0.620313366430235	8519/8651/6772/6890	4
WP4483	Relationship between inflammation, COX-2 and EGFR	4/679	23/6049	0.253940015534148	0.735842628326237	0.620313366430235	2099/4312/51365/5743	4
WP4585	Cancer immunotherapy by PD-1 blockade	4/679	23/6049	0.253940015534148	0.735842628326237	0.620313366430235	29126/3458/4776/80380	4
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	4/679	23/6049	0.253940015534148	0.735842628326237	0.620313366430235	3553/3569/10135/23057	4
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	11/679	78/6049	0.2554911265456	0.735842628326237	0.620313366430235	8061/11211/283120/5328/4920/6422/6423/64321/7020/7472/7474	11
WP3942	PPAR signaling pathway	8/679	54/6049	0.255674133570981	0.735842628326237	0.620313366430235	2180/2182/126129/4023/4312/4973/5346/28965	8
WP4241	Type 2 papillary renal cell carcinoma	5/679	31/6049	0.264156736711332	0.755648361986356	0.637009546901968	1513/3091/5155/7042/7043	5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	10/679	72/6049	0.285581947796758	0.812016140723313	0.68452743352679	8061/11211/5328/4920/6422/6423/64321/83595/7472/7474	10
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	3/679	17/6049	0.296569087390951	0.838207241009154	0.706606460975602	10631/3371/7472	3
WP428	Wnt signaling	13/679	98/6049	0.303471300468383	0.845159182374392	0.712466928941838	816/8061/11211/4776/5328/23236/166336/4920/6422/6423/64321/7472/7474	13
WP4655	Cytosolic DNA-sensing pathway	8/679	57/6049	0.306372958820629	0.845159182374392	0.712466928941838	834/6351/9560/3627/3553/90865/3569/81030	8
WP4950	16p11.2 distal deletion syndrome	4/679	25/6049	0.306375569204048	0.845159182374392	0.712466928941838	1380/8519/3791/5350	4
WP581	EPO receptor signaling	4/679	25/6049	0.306375569204048	0.845159182374392	0.712466928941838	5163/10076/8651/6772	4
WP4542	Leukocyte-intrinsic Hippo pathway functions	5/679	33/6049	0.309621701060331	0.845159182374392	0.712466928941838	50943/26524/4023/639/7004	5
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2/679	10/6049	0.311562918926153	0.845159182374392	0.712466928941838	1116/9021	2
WP4846	SARS-CoV-2 and COVID-19 pathway	2/679	10/6049	0.311562918926153	0.845159182374392	0.712466928941838	1514/8829	2
WP4217	Ebola virus infection in host	16/679	124/6049	0.314731685121014	0.848876316440679	0.71560046301199	87/432/684/11314/10332/93978/1514/26762/84868/3673/3678/3690/8503/9021/6772/7020	16
WP3877	MYD88 distinct input-output pathway	3/679	18/6049	0.328856465016448	0.862334730487576	0.72694587003636	3552/7097/51311	3
WP4533	Transcription co-factors SKI and SKIL protein partners	3/679	18/6049	0.328856465016448	0.862334730487576	0.72694587003636	26524/23314/7004	3
WP4760	PKC-gamma calcium signaling pathway in ataxia	3/679	18/6049	0.328856465016448	0.862334730487576	0.72694587003636	2769/5163/23236	3
WP4784	Proteoglycan biosynthesis	3/679	18/6049	0.328856465016448	0.862334730487576	0.72694587003636	9469/55790/1836	3
WP5149	Lipid metabolism in senescent cells	3/679	18/6049	0.328856465016448	0.862334730487576	0.72694587003636	50487/7941/5743	3
WP299	Nuclear receptors in lipid metabolism and toxicity	4/679	26/6049	0.333024722583035	0.868440160548026	0.732092731238077	19/8647/1594/1555	4
WP4658	Small cell lung cancer	12/679	93/6049	0.349274500996521	0.901815624948079	0.760228158408506	1282/1284/2335/3673/284217/3908/3910/3915/10319/4843/8503/5743	12
WP2586	Aryl hydrocarbon receptor pathway	6/679	43/6049	0.35140684717331	0.901815624948079	0.760228158408506	1543/1545/2099/4023/135112/5743	6
WP4947	Nitric oxide metabolism in cystic fibrosis	2/679	11/6049	0.354753263833505	0.901815624948079	0.760228158408506	4843/4846	2
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	2/679	11/6049	0.354753263833505	0.901815624948079	0.760228158408506	2358/5163	2
WP5102	Familial partial lipodystrophy (FPLD)	4/679	27/6049	0.359773717227056	0.901815624948079	0.760228158408506	2624/4023/5346/5396	4
WP3599	Transcription factor regulation in adipogenesis	3/679	19/6049	0.36110837524404	0.901815624948079	0.760228158408506	1051/3569/7291	3
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/679	19/6049	0.36110837524404	0.901815624948079	0.760228158408506	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/679	19/6049	0.36110837524404	0.901815624948079	0.760228158408506	2180/3651/55512	3
WP3945	TYROBP causal network in microglia	8/679	61/6049	0.376751278856286	0.932107804197369	0.785764384448273	3142/10261/3687/10008/4688/5341/6696/7305	8
WP2873	Aryl hydrocarbon receptor pathway	5/679	36/6049	0.379390461896468	0.932107804197369	0.785764384448273	1543/1545/3458/3553/8140	5
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	5/679	36/6049	0.379390461896468	0.932107804197369	0.785764384448273	684/8519/10581/10410/6196	5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4/679	28/6049	0.386493284423465	0.932107804197369	0.785764384448273	3082/7042/7043/7474	4
WP4481	Resistin as a regulator of inflammation	4/679	28/6049	0.386493284423465	0.932107804197369	0.785764384448273	3569/23236/5333/113026	4
WP3888	VEGFA-VEGFR2 signaling pathway	48/679	409/6049	0.391759363573491	0.932107804197369	0.785764384448273	9510/56999/301/81575/22899/813/6347/1003/79094/2022/2078/24147/2321/2335/6624/2523/2624/2697/3142/5654/3383/3490/3690/3791/9079/4319/4323/4313/79812/4688/91624/4846/4855/8013/8828/5228/5328/5329/9588/5743/57381/27289/6401/6648/6772/7004/8794/81567	48
WP3640	Imatinib and chronic myeloid leukemia	3/679	20/6049	0.393113621754742	0.932107804197369	0.785764384448273	2321/5159/11040	3
WP3645	NAD+ biosynthetic pathways	3/679	20/6049	0.393113621754742	0.932107804197369	0.785764384448273	3620/10135/6999	3
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	6/679	45/6049	0.393334106281158	0.932107804197369	0.785764384448273	19/2180/2182/9023/54898/3992	6
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2/679	12/6049	0.396935738651846	0.932107804197369	0.785764384448273	1634/6422	2
WP4211	Transcriptional cascade regulating adipogenesis	2/679	12/6049	0.396935738651846	0.932107804197369	0.785764384448273	1051/2624	2
WP5110	Familial hyperlipidemia type 3	2/679	12/6049	0.396935738651846	0.932107804197369	0.785764384448273	4023/7436	2
WP2876	Pregnane X receptor pathway	4/679	29/6049	0.41306427644802	0.960425312726431	0.809635968355465	1555/1577/1551/27286	4
WP4698	Vitamin D-sensitive calcium signaling in depression	4/679	29/6049	0.41306427644802	0.960425312726431	0.809635968355465	793/1594/2906/3786	4
WP4787	Osteoblast differentiation and related diseases	12/679	98/6049	0.420536733964794	0.973006560938151	0.820241926928236	2255/2247/2252/11211/2737/23493/4854/4855/8503/6772/7472/7474	12
WP383	Striated muscle contraction pathway	3/679	21/6049	0.424687696057056	0.977817524580149	0.824297556403427	59/4604/7134	3
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/679	13/6049	0.437792527549337	0.982067171848168	0.827879997677537	4312/5743	2
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	2/679	13/6049	0.437792527549337	0.982067171848168	0.827879997677537	3690/7134	2
WP4942	15q13.3 copy number variation syndrome	2/679	13/6049	0.437792527549337	0.982067171848168	0.827879997677537	1139/871	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/679	13/6049	0.437792527549337	0.982067171848168	0.827879997677537	8647/9420	2
WP143	Fatty acid beta-oxidation	4/679	30/6049	0.439378080554626	0.982067171848168	0.827879997677537	2180/2182/8513/4023	4
WP2839	Hair follicle development: organogenesis - part 2 of 3	4/679	30/6049	0.439378080554626	0.982067171848168	0.827879997677537	3624/6469/6615/7474	4
WP4806	EGFR tyrosine kinase inhibitor resistance	10/679	82/6049	0.44109796701655	0.982067171848168	0.827879997677537	2247/3082/3569/3791/22808/3084/5155/5159/8503/399694	10
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	8/679	65/6049	0.448015081173119	0.988145412680897	0.833003938433049	816/941/9076/1514/3690/4868/5329/7225	8
WP3303	RAC1/PAK1/p38/MMP2 pathway	8/679	65/6049	0.448015081173119	0.988145412680897	0.833003938433049	284/285/2335/4313/4843/7010/7075/79931	8
WP4595	Urea cycle and associated pathways	3/679	22/6049	0.455671817167189	0.999999928542221	0.842997263579303	4843/4846/5831	3
WP4222	Phosphodiesterases in neuronal function	5/679	40/6049	0.4717474245101	0.999999928542221	0.842997263579303	1139/2906/2977/10846/5142	5
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	2/679	14/6049	0.477089660199568	0.999999928542221	0.842997263579303	3589/3569	2
WP4584	Biomarkers for pyrimidine metabolism disorders	2/679	14/6049	0.477089660199568	0.999999928542221	0.842997263579303	1152/1890	2
WP47	Hedgehog signaling pathway	2/679	14/6049	0.477089660199568	0.999999928542221	0.842997263579303	2737/6469	2
WP5061	Fatty acid transporters	2/679	14/6049	0.477089660199568	0.999999928542221	0.842997263579303	2180/2182	2
WP58	Monoamine GPCRs	2/679	14/6049	0.477089660199568	0.999999928542221	0.842997263579303	147/3274	2
WP697	Estrogen metabolism	2/679	14/6049	0.477089660199568	0.999999928542221	0.842997263579303	1543/1545	2
WP3845	Canonical and non-canonical Notch signaling	3/679	23/6049	0.485931587412145	0.999999928542221	0.842997263579303	4237/4854/4855	3
WP4537	Hippo-Yap signaling pathway	3/679	23/6049	0.485931587412145	0.999999928542221	0.842997263579303	3627/26524/7004	3
WP4545	Oxysterols derived from cholesterol	4/679	32/6049	0.490853226692725	0.999999928542221	0.842997263579303	9023/9420/2099/3605	4
WP2332	Interleukin-11 signaling pathway	5/679	41/6049	0.494228952404978	0.999999928542221	0.842997263579303	3383/3589/3673/9021/6772	5
WP2855	Dopaminergic neurogenesis	2/679	15/6049	0.51466223701888	0.999999928542221	0.842997263579303	6469/6571	2
WP3	Transcriptional activation by NRF2 in response to phytochemicals	2/679	15/6049	0.51466223701888	0.999999928542221	0.842997263579303	1051/23657	2
WP5109	Familial hyperlipidemia type 2	2/679	15/6049	0.51466223701888	0.999999928542221	0.842997263579303	4023/255738	2
WP26	S1P receptor signal transduction	3/679	24/6049	0.515355391630705	0.999999928542221	0.842997263579303	23236/9294/8877	3
WP3529	Zinc homeostasis	4/679	33/6049	0.51585067850409	0.999999928542221	0.842997263579303	4494/4499/55532/29986	4
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	6/679	52/6049	0.536593461357055	0.999999928542221	0.842997263579303	308/79092/2149/3084/8767/9021	6
WP702	Metapathway biotransformation Phase I and II	14/679	125/6049	0.546492672965188	0.999999928542221	0.842997263579303	1645/9469/1543/1545/56603/1594/1555/1577/1551/9420/2328/64090/90161/4837	14
WP2884	NRF2 pathway	13/679	116/6049	0.546960940727738	0.999999928542221	0.842997263579303	874/3082/23764/3084/5155/9588/154091/6515/29986/160728/11254/23657/7042	13
WP4746	Thyroid hormones production and peripheral downstream signaling effects	9/679	80/6049	0.550284221364171	0.999999928542221	0.842997263579303	50506/405753/3690/23236/5346/6469/6567/7068/7253	9
WP3644	NAD+ metabolism	2/679	16/6049	0.550401907579937	0.999999928542221	0.842997263579303	10135/23057	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/679	16/6049	0.550401907579937	0.999999928542221	0.842997263579303	2180/2182	2
WP4558	Overview of interferons-mediated signaling pathway	2/679	16/6049	0.550401907579937	0.999999928542221	0.842997263579303	3458/6772	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/679	16/6049	0.550401907579937	0.999999928542221	0.842997263579303	3569/64386	2
WP4970	Galanin receptor pathway	2/679	16/6049	0.550401907579937	0.999999928542221	0.842997263579303	3569/7020	2
WP2359	Parkin-ubiquitin proteasomal system pathway	7/679	62/6049	0.553551737695862	0.999999928542221	0.842997263579303	834/2861/3310/6622/9627/347733/9246	7
WP4657	22q11.2 copy number variation syndrome	10/679	90/6049	0.564002794273078	0.999999928542221	0.842997263579303	59/150209/8854/9076/56603/2255/2296/9464/6469/7450	10
WP241	One-carbon metabolism	3/679	26/6049	0.571351933738264	0.999999928542221	0.842997263579303	10840/2346/219595	3
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	3/679	26/6049	0.571351933738264	0.999999928542221	0.842997263579303	5744/6615/6772	3
WP195	IL-1 signaling pathway	6/679	54/6049	0.57498362180125	0.999999928542221	0.842997263579303	6347/3552/3553/3554/3556/11213	6
WP4673	Male infertility	11/679	100/6049	0.576431590450666	0.999999928542221	0.842997263579303	1543/56603/2099/2346/219595/4313/4843/4846/29968/8787/6648	11
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	5/679	45/6049	0.580036641769533	0.999999928542221	0.842997263579303	6356/3055/3559/3569/6772	5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/679	17/6049	0.584246283605135	0.999999928542221	0.842997263579303	87/3690	2
WP5074	Kallmann syndrome	2/679	17/6049	0.584246283605135	0.999999928542221	0.842997263579303	23129/60675	2
WP4249	Hedgehog signaling pathway	4/679	37/6049	0.609464755811292	0.999999928542221	0.842997263579303	91653/2619/2737/6469	4
WP497	Urea cycle and metabolism of amino groups	2/679	18/6049	0.61617001092872	0.999999928542221	0.842997263579303	1152/5831	2
WP5033	Genes associated with the development of rheumatoid arthritis	2/679	18/6049	0.61617001092872	0.999999928542221	0.842997263579303	3559/23569	2
WP286	IL-3 signaling pathway	5/679	47/6049	0.619901367530085	0.999999928542221	0.842997263579303	1232/942/1439/3055/3563	5
WP2895	Differentiation of white and brown adipocyte	2/679	19/6049	0.646177262185741	0.999999928542221	0.842997263579303	1051/253738	2
WP325	Triacylglyceride synthesis	2/679	19/6049	0.646177262185741	0.999999928542221	0.842997263579303	8513/4023	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/679	19/6049	0.646177262185741	0.999999928542221	0.842997263579303	8708/8877	2
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	2/679	19/6049	0.646177262185741	0.999999928542221	0.842997263579303	3091/5163	2
WP5194	Synthesis of ceramides and 1-deoxyceramides	2/679	19/6049	0.646177262185741	0.999999928542221	0.842997263579303	53947/8877	2
WP3925	Amino acid metabolism	8/679	77/6049	0.646448507962773	0.999999928542221	0.842997263579303	127/586/3034/3067/5831/10993/6898/6999	8
WP3676	BDNF-TrkB signaling	3/679	29/6049	0.647397265681408	0.999999928542221	0.842997263579303	9456/4915/7225	3
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3/679	30/6049	0.670510508473273	0.999999928542221	0.842997263579303	4846/5163/8503	3
WP3580	Methionine de novo and salvage pathway	2/679	20/6049	0.674295444455852	0.999999928542221	0.842997263579303	259307/6898	2
WP4224	Purine metabolism and related disorders	2/679	20/6049	0.674295444455852	0.999999928542221	0.842997263579303	270/316	2
WP2007	Iron metabolism in placenta	1/679	10/6049	0.69626276095491	0.999999928542221	0.842997263579303	7018	1
WP3656	Interleukin-1 induced activation of NF-kB	1/679	10/6049	0.69626276095491	0.999999928542221	0.842997263579303	3552	1
WP4259	Disorders of folate metabolism and transport	1/679	10/6049	0.69626276095491	0.999999928542221	0.842997263579303	10840	1
WP4389	Bile acids synthesis and enterohepatic circulation 	1/679	10/6049	0.69626276095491	0.999999928542221	0.842997263579303	8647	1
WP5050	TCA cycle in senescence	1/679	10/6049	0.69626276095491	0.999999928542221	0.842997263579303	5163	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/679	10/6049	0.69626276095491	0.999999928542221	0.842997263579303	629	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/679	10/6049	0.69626276095491	0.999999928542221	0.842997263579303	51311	1
WP262	Ebstein-Barr virus LMP1 signaling	2/679	21/6049	0.700569944287305	0.999999928542221	0.842997263579303	6364/9260	2
WP4905	1q21.1 copy number variation syndrome	2/679	21/6049	0.700569944287305	0.999999928542221	0.842997263579303	2697/2702	2
WP4963	p53 transcriptional gene network	8/679	81/6049	0.702762290669474	0.999999928542221	0.842997263579303	6347/126129/6376/55332/3383/4688/5054/23657	8
WP357	Fatty acid biosynthesis	2/679	22/6049	0.725059756999316	0.999999928542221	0.842997263579303	2180/2182	2
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	2/679	22/6049	0.725059756999316	0.999999928542221	0.842997263579303	597/5744	2
WP229	Irinotecan pathway	1/679	11/6049	0.73041371066705	0.999999928542221	0.842997263579303	1577	1
WP3679	Cell-type dependent selectivity of CCK2R signaling	1/679	11/6049	0.73041371066705	0.999999928542221	0.842997263579303	23236	1
WP3871	Valproic acid pathway	1/679	11/6049	0.73041371066705	0.999999928542221	0.842997263579303	1555	1
WP3930	EDA signaling in hair follicle development	1/679	11/6049	0.73041371066705	0.999999928542221	0.842997263579303	6469	1
WP4271	Vitamin B12 disorders	1/679	11/6049	0.73041371066705	0.999999928542221	0.842997263579303	6947	1
WP4583	Biomarkers for urea cycle disorders	1/679	11/6049	0.73041371066705	0.999999928542221	0.842997263579303	2155	1
WP4788	Autosomal recessive osteopetrosis pathways	1/679	11/6049	0.73041371066705	0.999999928542221	0.842997263579303	29887	1
WP4919	Neuroinflammation	1/679	11/6049	0.73041371066705	0.999999928542221	0.842997263579303	4843	1
WP244	Alpha 6 beta 4 signaling pathway	3/679	33/6049	0.733102940540997	0.999999928542221	0.842997263579303	284217/3908/3915	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	3/679	33/6049	0.733102940540997	0.999999928542221	0.842997263579303	816/9586/1511	3
WP1772	Apoptosis modulation and signaling	8/679	84/6049	0.740988550453459	0.999999928542221	0.842997263579303	597/638/834/8739/3554/4671/5783/8794	8
WP2267	Synaptic vesicle pathway	4/679	44/6049	0.743843146156865	0.999999928542221	0.842997263579303	6571/6507/6812/6853	4
WP34	Ovarian infertility	2/679	23/6049	0.747833868388571	0.999999928542221	0.842997263579303	1051/2701	2
WP4357	NRF2-ARE regulation	2/679	23/6049	0.747833868388571	0.999999928542221	0.842997263579303	1051/23657	2
WP2023	Cell differentiation - expanded index	1/679	12/6049	0.760729889941159	0.999999928542221	0.842997263579303	10637	1
WP4792	Purine metabolism	1/679	12/6049	0.760729889941159	0.999999928542221	0.842997263579303	270	1
WP5112	Familial hyperlipidemia type 5	1/679	12/6049	0.760729889941159	0.999999928542221	0.842997263579303	4023	1
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	2/679	24/6049	0.768968275366558	0.999999928542221	0.842997263579303	247/2358	2
WP4925	Unfolded protein response	2/679	24/6049	0.768968275366558	0.999999928542221	0.842997263579303	3553/7494	2
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	2/679	24/6049	0.768968275366558	0.999999928542221	0.842997263579303	2769/23236	2
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	2/679	24/6049	0.768968275366558	0.999999928542221	0.842997263579303	3569/114548	2
WP4566	Translation inhibitors in chronically activated PDGFRA cells	4/679	46/6049	0.775021886997446	0.999999928542221	0.842997263579303	5163/8503/11040/6196	4
WP61	Notch signaling pathway	5/679	57/6049	0.78250345494629	0.999999928542221	0.842997263579303	1840/23493/3091/4854/4855	5
WP2289	Drug induction of bile acid pathway	1/679	13/6049	0.787641336807145	0.999999928542221	0.842997263579303	8647	1
WP3853	ERK pathway in Huntington's disease	1/679	13/6049	0.787641336807145	0.999999928542221	0.842997263579303	4915	1
WP5108	Familial  hyperlipidemia type 1	1/679	13/6049	0.787641336807145	0.999999928542221	0.842997263579303	4023	1
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	1/679	13/6049	0.787641336807145	0.999999928542221	0.842997263579303	3091	1
WP1528	Physiological and pathological hypertrophy of the heart	2/679	25/6049	0.788543547994657	0.999999928542221	0.842997263579303	2626/4776	2
WP205	IL-7 signaling pathway	2/679	25/6049	0.788543547994657	0.999999928542221	0.842997263579303	3559/6772	2
WP3613	Photodynamic therapy-induced unfolded protein response	2/679	25/6049	0.788543547994657	0.999999928542221	0.842997263579303	121506/7494	2
WP430	Statin inhibition of cholesterol production	2/679	25/6049	0.788543547994657	0.999999928542221	0.842997263579303	19/4023	2
WP1403	AMP-activated protein kinase (AMPK) signaling	5/679	58/6049	0.795320357234766	0.999999928542221	0.842997263579303	147/126129/5209/8503/23236	5
WP4262	Breast cancer pathway	12/679	129/6049	0.796813117890066	0.999999928542221	0.842997263579303	2099/2255/2247/2252/11211/23493/4854/4855/8503/399694/7472/7474	12
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	2/679	26/6049	0.806642849182689	0.999999928542221	0.842997263579303	1051/2099	2
WP3851	TLR4 signaling and tolerance	2/679	26/6049	0.806642849182689	0.999999928542221	0.842997263579303	3569/11213	2
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2/679	26/6049	0.806642849182689	0.999999928542221	0.842997263579303	4915/8503	2
WP2879	Farnesoid X receptor pathway	1/679	14/6049	0.81152992731542	0.999999928542221	0.842997263579303	8647	1
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/679	14/6049	0.81152992731542	0.999999928542221	0.842997263579303	283120	1
WP3611	Photodynamic therapy-induced AP-1 survival signaling	4/679	49/6049	0.816082779552421	0.999999928542221	0.842997263579303	2252/3458/3569/4313	4
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4/679	49/6049	0.816082779552421	0.999999928542221	0.842997263579303	1051/1513/6696/7042	4
WP4758	Nephrotic syndrome	3/679	38/6049	0.816113581515545	0.999999928542221	0.842997263579303	8542/4868/7225	3
WP5098	T-cell activation SARS-CoV-2	7/679	81/6049	0.819385638710344	0.999999928542221	0.842997263579303	941/942/3458/3595/3605/8809/3937	7
WP2112	IL-17 signaling pathway	2/679	27/6049	0.823350340253131	0.999999928542221	0.842997263579303	1051/3605	2
WP2643	Nanoparticle-mediated activation of receptor signaling	2/679	27/6049	0.823350340253131	0.999999928542221	0.842997263579303	1277/2335	2
WP2875	Constitutive androstane receptor pathway	2/679	27/6049	0.823350340253131	0.999999928542221	0.842997263579303	1555/1577	2
WP2526	PDGF pathway	3/679	39/6049	0.829800594474852	0.999999928542221	0.842997263579303	5155/5159/6772	3
WP2828	Bladder cancer	3/679	39/6049	0.829800594474852	0.999999928542221	0.842997263579303	4312/4313/1890	3
WP4313	Ferroptosis	5/679	61/6049	0.830229049643577	0.999999928542221	0.842997263579303	2180/2182/1645/23657/7018	5
WP4962	Airway smooth muscle cell contraction	1/679	15/6049	0.832734762336601	0.999999928542221	0.842997263579303	23236	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/679	15/6049	0.832734762336601	0.999999928542221	0.842997263579303	3091	1
WP4150	Wnt signaling in kidney disease	2/679	28/6049	0.838749910890479	0.999999928542221	0.842997263579303	7472/7474	2
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2/679	28/6049	0.838749910890479	0.999999928542221	0.842997263579303	59/9104	2
WP5224	2q37 copy number variation syndrome	9/679	104/6049	0.840422118477697	0.999999928542221	0.842997263579303	19/10203/1293/6373/64090/3553/3690/129807/3651	9
WP3940	One-carbon metabolism and related pathways	3/679	40/6049	0.842604725238322	0.999999928542221	0.842997263579303	586/23743/6648	3
WP4312	Rett syndrome causing genes	3/679	40/6049	0.842604725238322	0.999999928542221	0.842997263579303	23314/85358/6812	3
WP395	IL-4 signaling pathway	4/679	52/6049	0.850785452356842	0.999999928542221	0.842997263579303	1051/8651/9021/6772	4
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1/679	16/6049	0.851556952653712	0.999999928542221	0.842997263579303	19	1
WP22	IL-9 signaling pathway	1/679	16/6049	0.851556952653712	0.999999928542221	0.842997263579303	6772	1
WP4225	Pyrimidine metabolism and related diseases	1/679	16/6049	0.851556952653712	0.999999928542221	0.842997263579303	1890	1
WP3972	PDGFR-beta pathway	2/679	29/6049	0.852924180905966	0.999999928542221	0.842997263579303	5159/6772	2
WP408	Oxidative stress response	2/679	29/6049	0.852924180905966	0.999999928542221	0.842997263579303	1543/6648	2
WP268	Notch signaling	3/679	41/6049	0.854566507015057	0.999999928542221	0.842997263579303	1840/4854/4855	3
WP4290	Metabolic reprogramming in colon cancer	3/679	41/6049	0.854566507015057	0.999999928542221	0.842997263579303	3101/29968/5831	3
WP49	IL-2 signaling pathway	3/679	41/6049	0.854566507015057	0.999999928542221	0.842997263579303	3559/9021/6772	3
WP2034	Leptin signaling pathway	6/679	75/6049	0.861298526735087	0.999999928542221	0.842997263579303	2099/3553/3557/4846/9021/6772	6
WP69	T-cell receptor signaling pathway	7/679	86/6049	0.863662177945774	0.999999928542221	0.842997263579303	3601/3605/3552/3553/3569/3937/8767	7
WP4917	Proximal tubule transport	3/679	42/6049	0.86572679346123	0.999999928542221	0.842997263579303	760/762/160728	3
WP3858	Toll-like receptor signaling related to MyD88	2/679	30/6049	0.865953728936872	0.999999928542221	0.842997263579303	7097/51311	2
WP4149	White fat cell differentiation	2/679	30/6049	0.865953728936872	0.999999928542221	0.842997263579303	1051/2624	2
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	2/679	30/6049	0.865953728936872	0.999999928542221	0.842997263579303	6772/7097	2
WP2853	Endoderm differentiation	10/679	118/6049	0.867442354915747	0.999999928542221	0.842997263579303	1846/2626/3227/3915/5744/6422/154091/64321/83595/6772	10
WP4912	SARS coronavirus and innate immunity	1/679	17/6049	0.868263869469248	0.999999928542221	0.842997263579303	6772	1
WP5111	Familial hyperlipidemia type 4	1/679	17/6049	0.868263869469248	0.999999928542221	0.842997263579303	4023	1
WP5200	Dravet syndrome	1/679	17/6049	0.868263869469248	0.999999928542221	0.842997263579303	6324	1
WP2018	RANKL/RANK signaling pathway	4/679	54/6049	0.870706661476166	0.999999928542221	0.842997263579303	1513/3383/6688/6772	4
WP399	Wnt signaling pathway and pluripotency	7/679	87/6049	0.8713600602451	0.999999928542221	0.842997263579303	8061/11211/120892/4316/5328/7472/7474	7
WP1971	Integrated cancer pathway	3/679	43/6049	0.876126370853736	0.999999928542221	0.842997263579303	994/4312/6772	3
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	3/679	43/6049	0.876126370853736	0.999999928542221	0.842997263579303	59/3690/7004	3
WP366	TGF-beta signaling pathway	11/679	130/6049	0.877862032002408	0.999999928542221	0.842997263579303	1278/2335/2354/50943/3673/3690/4312/4321/5163/7015/3371	11
WP4844	Influence of laminopathies on Wnt signaling	2/679	31/6049	0.877916509828607	0.999999928542221	0.842997263579303	1051/6696	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/679	31/6049	0.877916509828607	0.999999928542221	0.842997263579303	5163/23236	2
WP4223	Ras signaling	14/679	161/6049	0.879108674990921	0.999999928542221	0.842997263579303	2321/59345/2791/51764/3791/22808/4915/5159/8503/51365/50487/115727/399694/7010	14
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/679	18/6049	0.883092919971632	0.999999928542221	0.842997263579303	22808	1
WP4971	Phosphoinositides metabolism	3/679	44/6049	0.885805631197409	0.999999928542221	0.842997263579303	23236/5333/113026	3
WP3298	Melatonin metabolism and effects	2/679	32/6049	0.888887428157095	0.999999928542221	0.842997263579303	1543/1545	2
WP1584	Type II diabetes mellitus	1/679	19/6049	0.896254900959737	0.999999928542221	0.842997263579303	3651	1
WP5103	Progeria-associated lipodystrophy	1/679	19/6049	0.896254900959737	0.999999928542221	0.842997263579303	2200	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/679	19/6049	0.896254900959737	0.999999928542221	0.842997263579303	2626	1
WP3931	Embryonic stem cell pluripotency pathways	7/679	91/6049	0.898645031746705	0.999999928542221	0.842997263579303	2255/2247/2252/5155/5159/7472/7474	7
WP1544	MicroRNAs in cardiomyocyte hypertrophy	6/679	80/6049	0.898696275779871	0.999999928542221	0.842997263579303	2247/2626/4776/3084/8503/7474	6
WP3981	miRNA regulation of prostate cancer signaling pathways	2/679	33/6049	0.898938040261359	0.999999928542221	0.842997263579303	354/5159	2
WP5180	DYRK1A	4/679	58/6049	0.903758031559435	0.999999928542221	0.842997263579303	273/2247/3092/26524	4
WP2878	PPAR-alpha pathway	1/679	20/6049	0.907936977617837	0.999999928542221	0.842997263579303	55554	1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/679	20/6049	0.907936977617837	0.999999928542221	0.842997263579303	3002	1
WP4725	Sphingolipid metabolism overview	1/679	20/6049	0.907936977617837	0.999999928542221	0.842997263579303	8877	1
WP170	Nuclear receptors	2/679	34/6049	0.908136361378038	0.999999928542221	0.842997263579303	2099/7068	2
WP400	p38 MAPK signaling pathway	2/679	34/6049	0.908136361378038	0.999999928542221	0.842997263579303	6772/7042	2
WP710	DNA damage response (only ATM dependent)	8/679	104/6049	0.910581512553877	0.999999928542221	0.842997263579303	638/8061/5163/8503/5328/6648/7472/7474	8
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	4/679	59/6049	0.910755857713331	0.999999928542221	0.842997263579303	1437/3458/3937/5163	4
WP185	Integrin-mediated cell adhesion	7/679	94/6049	0.915741846091836	0.999999928542221	0.842997263579303	11131/22801/3673/3678/8516/3687/3690	7
WP382	MAPK signaling pathway	18/679	210/6049	0.915849313189791	0.999999928542221	0.842997263579303	777/994/1846/2255/2247/2252/3310/3552/3553/3554/120892/22808/4915/5155/5159/115727/7042/7043	18
WP51	Regulation of actin cytoskeleton	10/679	127/6049	0.917446714588964	0.999999928542221	0.842997263579303	87/2149/2255/2247/2252/2335/22808/5155/5159/8503	10
WP4288	MTHFR deficiency	1/679	21/6049	0.918305329284363	0.999999928542221	0.842997263579303	2906	1
WP4726	Sphingolipid metabolism: integrated pathway	1/679	21/6049	0.918305329284363	0.999999928542221	0.842997263579303	8877	1
WP4630	Measles virus infection	9/679	117/6049	0.920990716114153	0.999999928542221	0.842997263579303	10332/3310/3552/3553/3559/3569/8503/6772/7097	9
WP2447	Amyotrophic lateral sclerosis (ALS)	2/679	36/6049	0.924229909439418	0.999999928542221	0.842997263579303	834/4741	2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/679	36/6049	0.924229909439418	0.999999928542221	0.842997263579303	3488/5163	2
WP623	Oxidative phosphorylation	2/679	36/6049	0.924229909439418	0.999999928542221	0.842997263579303	3002/56901	2
WP2272	Pathogenic Escherichia coli infection	3/679	49/6049	0.924752887078904	0.999999928542221	0.842997263579303	9076/23643/347733	3
WP2637	Interleukin-1 (IL-1) structural pathway	3/679	49/6049	0.924752887078904	0.999999928542221	0.842997263579303	3552/3554/3556	3
WP363	Wnt signaling pathway	3/679	49/6049	0.924752887078904	0.999999928542221	0.842997263579303	2697/4920/7010	3
WP4482	Vitamin D in inflammatory diseases	1/679	22/6049	0.927507499393175	0.999999928542221	0.842997263579303	3569	1
WP4686	Leucine, isoleucine and valine metabolism	1/679	22/6049	0.927507499393175	0.999999928542221	0.842997263579303	586	1
WP712	Estrogen signaling pathway	1/679	22/6049	0.927507499393175	0.999999928542221	0.842997263579303	2099	1
WP4932	7q11.23 copy number variation syndrome	6/679	86/6049	0.9318679315132	0.999999928542221	0.842997263579303	9076/2199/2200/3084/9246/7472	6
WP2037	Prolactin signaling pathway	5/679	75/6049	0.934714919085592	0.999999928542221	0.842997263579303	4843/6196/8651/9021/6772	5
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/679	23/6049	0.935674482620657	0.999999928542221	0.842997263579303	5054	1
WP5064	7-oxo-C and 7-beta-HC pathways	1/679	23/6049	0.935674482620657	0.999999928542221	0.842997263579303	3290	1
WP3286	Copper homeostasis	3/679	51/6049	0.936596655534754	0.999999928542221	0.842997263579303	4494/26872/79689	3
WP500	Glycogen synthesis and degradation	2/679	38/6049	0.937638891557486	0.999999928542221	0.842997263579303	3101/5255	2
WP127	IL-5 signaling pathway	2/679	39/6049	0.943467988697088	0.999999928542221	0.842997263579303	1439/6772	2
WP4549	Fragile X syndrome	7/679	101/6049	0.946248482492954	0.999999928542221	0.842997263579303	816/80852/9456/4131/4915/5163/23236	7
WP585	Interferon type I signaling pathways	3/679	53/6049	0.946698392669157	0.999999928542221	0.842997263579303	8651/9021/6772	3
WP2355	Corticotropin-releasing hormone signaling pathway	5/679	78/6049	0.947616489495644	0.999999928542221	0.842997263579303	2354/8061/2697/4846/7020	5
WP534	Glycolysis and gluconeogenesis	2/679	40/6049	0.948776581510707	0.999999928542221	0.842997263579303	3101/6515	2
WP3965	Lipid metabolism pathway	1/679	25/6049	0.949355038196292	0.999999928542221	0.842997263579303	5346	1
WP314	Fas ligand pathway and stress induction of heat shock proteins	2/679	41/6049	0.953607867382279	0.999999928542221	0.842997263579303	3552/8767	2
WP1422	Sphingolipid pathway	1/679	26/6049	0.955063525756836	0.999999928542221	0.842997263579303	8877	1
WP4906	3q29 copy number variation syndrome	3/679	55/6049	0.955287085219462	0.999999928542221	0.842997263579303	3091/8503/7018	3
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	2/679	42/6049	0.958001921078331	0.999999928542221	0.842997263579303	6347/3569	2
WP2525	Trans-sulfuration and one-carbon metabolism	1/679	27/6049	0.960129417506979	0.999999928542221	0.842997263579303	29968	1
WP3869	Cannabinoid receptor signaling	1/679	27/6049	0.960129417506979	0.999999928542221	0.842997263579303	1543	1
WP3996	Ethanol effects on histone modifications	1/679	27/6049	0.960129417506979	0.999999928542221	0.842997263579303	8854	1
WP4204	Tumor suppressor activity of SMARCB1	1/679	27/6049	0.960129417506979	0.999999928542221	0.842997263579303	2737	1
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2/679	43/6049	0.96199585035758	0.999999928542221	0.842997263579303	7042/7043	2
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	4/679	70/6049	0.96258397844593	0.999999928542221	0.842997263579303	9423/5743/7042/7043	4
WP673	ErbB signaling pathway	5/679	83/6049	0.96407984275396	0.999999928542221	0.842997263579303	816/3084/145957/8503/399694	5
WP2583	T cell receptor and co-stimulatory signaling	1/679	28/6049	0.964624954789071	0.999999928542221	0.842997263579303	5163	1
WP5038	Mitochondrial immune response to SARS-CoV-2	1/679	28/6049	0.964624954789071	0.999999928542221	0.842997263579303	1514	1
WP4255	Non-small cell lung cancer	4/679	71/6049	0.9655367994931	0.999999928542221	0.842997263579303	1381/1382/5163/8503	4
WP5205	Clock-controlled autophagy in bone metabolism	4/679	71/6049	0.9655367994931	0.999999928542221	0.842997263579303	115908/1513/3569/7474	4
WP2038	Microtubule cytoskeleton regulation	2/679	44/6049	0.965623956031874	0.999999928542221	0.842997263579303	2151/4131	2
WP410	Exercise-induced circadian regulation	2/679	44/6049	0.965623956031874	0.999999928542221	0.842997263579303	1051/50486	2
WP3680	Physico-chemical features and toxicity-associated pathways	3/679	58/6049	0.965775748257653	0.999999928542221	0.842997263579303	2335/11211/4741	3
WP4659	Gastrin signaling pathway	7/679	108/6049	0.966512752341947	0.999999928542221	0.842997263579303	9076/3067/4316/8503/5743/5054/7032	7
WP1601	Fluoropyrimidine activity	1/679	29/6049	0.968614268142039	0.999999928542221	0.842997263579303	1890	1
WP183	Proteasome degradation	3/679	59/6049	0.968723242393956	0.999999928542221	0.842997263579303	3458/5698/7345	3
WP304	Kit receptor signaling pathway	3/679	59/6049	0.968723242393956	0.999999928542221	0.842997263579303	6615/8651/6772	3
WP4321	Thermogenesis	6/679	98/6049	0.970864643391566	0.999999928542221	0.842997263579303	2180/2182/126129/9586/5346/6196	6
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	9/679	134/6049	0.97205745712222	0.999999928542221	0.842997263579303	249/55816/4688/4776/4915/399694/6696/6772/6853	9
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/679	31/6049	0.975295545965545	0.999999928542221	0.842997263579303	4776	1
WP3594	Circadian rhythm genes	11/679	159/6049	0.975607301509258	0.999999928542221	0.842997263579303	134/56938/2155/9456/3569/10135/22871/4843/4887/60675/5054	11
WP4396	Nonalcoholic fatty liver disease	9/679	137/6049	0.977026132019871	0.999999928542221	0.842997263579303	6347/84701/3552/3553/3569/56901/8503/9021/7494	9
WP3995	Prion disease pathway	1/679	32/6049	0.978082904604527	0.999999928542221	0.842997263579303	6688	1
WP3998	Prader-Willi and Angelman syndrome	1/679	32/6049	0.978082904604527	0.999999928542221	0.842997263579303	4948	1
WP2059	Alzheimer's disease and miRNA effects	17/679	229/6049	0.980023019692208	0.999999928542221	0.842997263579303	1139/11211/2906/3552/3553/3569/4023/407024/4843/8503/23236/5743/6622/347733/7472/7474/7494	17
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	3/679	64/6049	0.980193447992627	0.999999928542221	0.842997263579303	23236/6772/7253	3
WP4874	CAMKK2 pathway	1/679	33/6049	0.980556181615251	0.999999928542221	0.842997263579303	3383	1
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	1/679	33/6049	0.980556181615251	0.999999928542221	0.842997263579303	6772	1
WP313	Hepatocyte growth factor receptor signaling	1/679	34/6049	0.982750721622439	0.999999928542221	0.842997263579303	3082	1
WP4949	16p11.2 proximal deletion syndrome	3/679	67/6049	0.985015188180266	0.999999928542221	0.842997263579303	253982/2099/653808	3
WP2795	Cardiac hypertrophic response	2/679	53/6049	0.986288836689765	0.999999928542221	0.842997263579303	2247/3084	2
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	2/679	53/6049	0.986288836689765	0.999999928542221	0.842997263579303	3627/3458	2
WP4205	MET in type 1 papillary renal cell carcinoma	2/679	53/6049	0.986288836689765	0.999999928542221	0.842997263579303	3082/8503	2
WP5124	Alzheimer's disease	16/679	226/6049	0.987178963702005	0.999999928542221	0.842997263579303	1139/11211/2906/3552/3553/3569/4023/4843/8503/23236/5743/6622/347733/7472/7474/7494	16
WP4666	Hepatitis B infection	8/679	134/6049	0.987531359212042	0.999999928542221	0.842997263579303	9586/3569/4776/8503/6772/7042/7043/7097	8
WP2857	Mesodermal commitment pathway	7/679	122/6049	0.987785141292101	0.999999928542221	0.842997263579303	2296/3624/10637/4211/154091/6615/64321	7
WP2516	ATM signaling pathway	1/679	37/6049	0.987958407452822	0.999999928542221	0.842997263579303	8120	1
WP4148	Splicing factor NOVA regulated synaptic proteins	1/679	37/6049	0.987958407452822	0.999999928542221	0.842997263579303	2898	1
WP35	G protein signaling pathways	4/679	85/6049	0.989586002076131	0.999999928542221	0.842997263579303	2769/2791/51764/5142	4
WP3584	MECP2 and associated Rett syndrome	2/679	56/6049	0.989963484058811	0.999999928542221	0.842997263579303	2247/6890	2
WP5085	Vasopressin-regulated water reabsorption	1/679	39/6049	0.990524983991855	0.999999928542221	0.842997263579303	9586	1
WP4263	Pancreatic adenocarcinoma pathway	4/679	87/6049	0.99127688161641	0.999999928542221	0.842997263579303	8503/6772/7042/7043	4
WP5220	Metabolic reprogramming in pancreatic cancer	1/679	41/6049	0.992545145562047	0.999999928542221	0.842997263579303	8140	1
WP5072	Modulators of TCR signaling and T cell activation	2/679	59/6049	0.992670897077376	0.999999928542221	0.842997263579303	3937/8651	2
WP481	Insulin signaling	9/679	156/6049	0.993827880850578	0.999999928542221	0.842997263579303	30846/8503/57381/6196/10110/8651/9021/6812/7494	9
WP4155	Endometrial cancer	2/679	61/6049	0.994064011581945	0.999999928542221	0.842997263579303	2247/8503	2
WP437	EGF/EGFR signaling pathway	9/679	157/6049	0.994259203977068	0.999999928542221	0.842997263579303	54206/2354/2697/4846/7837/6196/6772/6812/7291	9
WP4861	Endoplasmic reticulum stress response in coronavirus infection	1/679	44/6049	0.99479813691395	0.999999928542221	0.842997263579303	7494	1
WP4685	Melanoma	2/679	63/6049	0.995196781152999	0.999999928542221	0.842997263579303	3791/8503	2
WP3915	Angiopoietin-like protein 8 regulatory pathway	6/679	126/6049	0.996805723905444	0.999999928542221	0.842997263579303	1555/4023/8503/6196/6567/7068	6
WP254	Apoptosis	3/679	84/6049	0.99708591757597	0.999999928542221	0.842997263579303	834/3002/8739	3
WP4656	Joubert syndrome	2/679	71/6049	0.997958057579924	0.999999928542221	0.842997263579303	27077/6469	2
WP231	TNF-alpha signaling pathway	3/679	92/6049	0.998687831056698	0.999999928542221	0.842997263579303	6347/3569/6401	3
WP3651	Pathways affected in adenoid cystic carcinoma	1/679	58/6049	0.999032273475207	0.999999928542221	0.842997263579303	4603	1
WP2261	Glioblastoma signaling pathways	2/679	82/6049	0.999381813885102	0.999999928542221	0.842997263579303	54206/5159	2
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/679	66/6049	0.999630543817993	0.999999928542221	0.842997263579303	4023	1
WP4536	Genes related to primary cilium development (based on CRISPR)	2/679	93/6049	0.999816126876687	0.999999928542221	0.842997263579303	27077/23552	2
WP4674	Head and neck squamous cell carcinoma	1/679	72/6049	0.999820720540137	0.999999928542221	0.842997263579303	7015	1
WP179	Cell cycle	3/679	115/6049	0.999876897269972	0.999999928542221	0.842997263579303	994/7042/7043	3
WP4022	Pyrimidine metabolism	1/679	81/6049	0.999939486365842	0.999999928542221	0.842997263579303	1890	1
WP138	Androgen receptor signaling pathway	1/679	85/6049	0.999962677032321	0.999999928542221	0.842997263579303	354	1
WP2446	Retinoblastoma gene in cancer	1/679	86/6049	0.99996692624343	0.999999928542221	0.842997263579303	994	1
WP477	Cytoplasmic ribosomal proteins	1/679	86/6049	0.99996692624343	0.999999928542221	0.842997263579303	6196	1
WP23	B cell receptor signaling pathway	1/679	96/6049	0.999990136253716	0.999999928542221	0.842997263579303	1380	1
WP4803	Ciliopathies	3/679	144/6049	0.999994444749414	0.999999928542221	0.842997263579303	27077/10309/2737	3
WP4352	Ciliary landscape	4/679	203/6049	0.999999928542221	0.999999928542221	0.842997263579303	3934/4741/7020/7022	4
